Freshly isolated Vα24+ CD4+ invariant natural killer T cells activated by α-galactosylceramide-pulsed B cells promote both IgG and IgE production

Clinical and Experimental Immunology

Volumn 148, Issue 3, 2007, Pages 555-563

  Rossignol, A ^a   Barra, A ^a   Herbelin, A ^b   Preud'homme, J L ^a   Gombert, J M ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b CNRS   (France)

Author keywords

B cells; Dendritic cells; Human studies; Immunoglobulins; iNK T cells

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 4; ALPHA-GALACTOSYLCERAMIDE; CYTOKINE; GALACTOSYLCERAMIDE; LYMPHOCYTE ANTIGEN RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL INTERACTION; CELL ISOLATION; COCULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN SECRETION; T LYMPHOCYTE ACTIVATION; TH2 CELL; BIOSYNTHESIS; CELL PROLIFERATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; T LYMPHOCYTE SUBPOPULATION;

B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; GALACTOSYLCERAMIDES; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COOPERATION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS; TH2 CELLS;

EID: 34247850792     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03364.x     Document Type: Article

References (35)

1. Godfrey DI, Hammond KJL, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today 2000 21:573 83.
2. Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002 2:557 68.
3. MacDonald HR. Development and selection of NKT cells. Curr Opin Immunol 2002 14:250 4.
4. Dellabona P, Padovan E, Casorati G, Brockhaus M, Lanzavecchia A. An invariant Vα24-JαQ/Vβ11 T cell receptor is expressed in all individuals by clonally expanded CD4-CD8- T cells. J Exp Med 1994 180:1171 6.
5. Exley M, Garcia J, Balk SP, Porcelli S. Requirements for CD1d recognition by human invariant Vα24+ CD4-CD8- T cells. J Exp Med 1997 186:109 20.
6. Kawano T, Cui J, Koezuka Y et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 1997 278:1626 9.
7. Spada FM, Koezuka Y, Porcelli SA. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med 1998 188:1529 34.
8. Zhou D, Mattner J, Cantu C et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 2004 306:1786 9.
9. Mattner J, DeBord KL, Ismail N et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005 434:525 9.
10. Wu D, Xing GW, Poles MA et al. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc Natl Acad Sci USA 2005 102:1351 6.
11. Chen H, Paul W. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1. J Immunol 1997 159:2240 9.
12. Lehuen A, Lantz O, Beaudoin L et al. Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes. J Exp Med 1998 188:1831 9.
13. Sharif S, Arreaza GA, Zucker P et al. Activation of natural killer T cells by α-galactosylceramide treatments prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 2001 7:1057 62.
14. Apostolou I, Takahama Y, Belmant C et al. Murine natural killer T (NKT) cells contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci USA 1999 96:5141 6.
15. Kumar H, Belperron SW, Bockenstedt LK. Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J Immunol 2000 165:4797 801.
16. Terabe M, Matsui S, Noben-Trauth N et al. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 2000 1:515 20.
17. Moodycliffe AM, Nghiem D, Clydesdale G, Ullrich SE. Immune suppression and skin cancer development: regulation by NKT cells. Nat Immunol 2000 1:521 5.
18. Crowe NY, Smyth MJ. Godfrey DI. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. J Exp Med 2002 196:119 27.
19. Burdin N, Brossay L, Kronenberg M. Immunization with α- galactosylceramide polarizes CD1-reactive NKT cells towards Th2 cytokine synthesis. Eur J Immunol 1999 29:2014 25.
20. Singh N, Hong S, Scherer DC et al. Activation of NKT cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol 1999 163:2373 7.
21. Kitamura H, Ohta A, Sekimoto M et al. α-Galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Cell Immunol 2000 199:37 42.
22. Zhang Y, Rogers KH, Lewis DB. Beta 2-microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses. J Exp Med 1996 184:1507 12.
23. Cui J, Watanabe N, Kawano T et al. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer T cells. J Exp Med 1999 190:783 92.
24. Kitamura H, Iwakabe K, Yahata T et al. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med 1999 189:1121 7.
25. Van Der Vliet HJJ, Nishi N, Koezuka Y et al. Potent expansion of human natural killer T cells using α-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15. J Immunol Meth 2001 247:61 72.
26. Galli G, Nuti S, Tavarini S et al. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J Exp Med 2003 197:1051 7.
27. Gumperz JE, Miyake S, Yamamura T, Brenner MB. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 2002 195:625 36.
28. Lee PT, Benlagha K, Teyton L, Bendelac A. Distinct functional lineages of human Vα24 natural killer T cells. J Exp Med 2002 195:637 41.
29. Levan-Petit I, Lelievre E, Barra A et al. T(h)2 cytokine dependence of IgD production by normal human B cells. Int Immunol 1999 11:1819 28.
30. Hameg A, Apostolou I, Leite-de-Moraes M et al. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules and autopresents the α-galactosylceramide antigen. J Immunol 2000 165:4917 26.
31. Kadowaki N, Antonenko S, Ho S et al. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J Exp Med 2001 193:1221 6.
32. Roark JH, Park SH, Jayawardena J, Kavita U, Shannon M, Bendelac A. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J Immunol 1998 160:3121 7.
33. Stern LJ, Wiley DC. The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide. Cell 1992 68:465 77.
34. Schofield L, McConville M, Hansen A et al. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 1999 283:225 9.
35. Hayakawa Y, Takeda K, Yagita H, Van Kaer L, Saiki I, Okumura K. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J Immunol 2001 166:6012 8.